Peer-Reviewed Study: bioAffinity Technologies' CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and OverdiagnosisBusiness Wire • Wednesday
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFOBusiness Wire • 08/23/24
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesBusiness Wire • 08/14/24
WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionPRNewsWire • 08/05/24
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionBusiness Wire • 08/05/24
WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionPRNewsWire • 08/02/24
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionBusiness Wire • 08/02/24
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVAccesswire • 07/12/24
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® LungBusiness Wire • 07/09/24
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVAccesswire • 07/05/24
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsBusiness Wire • 06/12/24
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesBusiness Wire • 05/15/24
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthBusiness Wire • 04/24/24
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningBusiness Wire • 04/09/24
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsBusiness Wire • 04/01/24
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementPRNewsWire • 03/08/24
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementBusiness Wire • 03/08/24
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementPRNewsWire • 03/06/24
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementBusiness Wire • 03/06/24
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies' Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeBusiness Wire • 02/06/24
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerBusiness Wire • 01/23/24